These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. CD5+ follicular lymphoma: a clinicopathologic study of three cases. Barry TS, Jaffe ES, Kingma DW, Martin AW, Sorbara L, Raffeld M, Pittaluga S. Am J Clin Pathol; 2002 Oct; 118(4):589-98. PubMed ID: 12375647 [Abstract] [Full Text] [Related]
26. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice. Samardzic T, Gerlach J, Muller K, Marinkovic D, Hess J, Nitschke L, Wirth T. Eur J Immunol; 2002 Sep; 32(9):2481-9. PubMed ID: 12207332 [Abstract] [Full Text] [Related]
27. Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients. Amen F, Horncastle D, Elderfield K, Banham AH, Bower M, Macdonald D, Kanfer E, Naresh KN. Histopathology; 2007 Jul; 51(1):70-9. PubMed ID: 17593082 [Abstract] [Full Text] [Related]
38. Analysis of cis-acting elements present in the CD20/B1 antigen promoter. Rieckmann P, Wilson GL, Thevenin C, Hong JX, Kehrl JH. J Immunol; 1991 Dec 01; 147(11):3994-9. PubMed ID: 1719097 [Abstract] [Full Text] [Related]
40. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites. Lennartsson A, Garwicz D, Lindmark A, Gullberg U. Gene; 2005 Aug 15; 356():193-202. PubMed ID: 16019164 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]